Parliament had earlier directed the Ministry of Health to suspend the trial with immediate effect.
Ghana's parliament is likely to rescind its decision on the suspension of an Ebola vaccination trial in the country.
The Food and Drugs Authority had earlier in June given an international pharmaceutical company approval to commence Ebola Vaccines trial in Ghana with the aim of getting a cure for the deadly disease.
But, some Ghanaians raised concerns over the exercise due to fears the trial will pose health hazards to people.
This prompted Parliament to direct the Ministry of Health to suspend the trial with immediate effect.
However, five months on, parliament is likely to reverse its directive following a report submitted to the House by the Health Committee in Parliament which is indicating that the exercise should continue.
The report which was signed by Joseph Yieleh Chireh, Chairman of Parliament’s Committee on Health said “After interaction with key stakeholders, the Committee was persuaded that there had been no Ebola clinical trials going on in the country. However, the FDA has approved a vaccine, namely the Johnson Ebola vaccine trials as part of an international effort to find a cure to the deadly Ebola Virus Disease. A second vaccine, the GSK vaccine is currently been considered for approval.”
The report added that “the Committee was convinced that the vaccine approved for clinical trials is safe and that most of the concerns about the vaccine can only be answered after the clinical trials have been undertaken.”
The report also recommended to Parliament to “urge the Minister of Health to intensify education on the clinicals. The Committee also resolved to undertake follow-ups on all the processes involved with these scientific exercises.”